EDGAR Filing Documents for 0000899140-05-000909

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0000899140-05-000909

Filing Date

2005-10-06

Accepted

2005-10-06 17:14:21

Documents

Group Members

WARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLC

Document Format Files

Seq	Description	Document	Type	Size
1	INITIAL FILING	w3002432b.txt	SC 13D	64847
3	LOCK-UP LETTER AGREEMENT	w3002432c.txt	EX-99.A	12446
4	JOINT FILING AGREEMENT	w3002432d.txt	EX-99.B	2542
	Complete submission text file	0000899140-05-000909.txt		82145

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13D | Act: 34 | File No.: 005-81034 | Film No.: 051127750
SIC: 2834 Pharmaceutical Preparations

Mailing Address

Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600

WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)

Type: SC 13D